Synapse - Chau Dang

Results (273)

Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)

Meeting Abstract

Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
Breast Cancer Research and Treatment (2005)

Fulltext@MSK | Save

Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments

Journal Article

Dang, C. T.; Dannenberg, A. J.; Subbaramaiah, K.; Dickler, M. N.; Moasser, M. M.; Seidman, A. D.; D'Andrea, G. M.; Theodoulou, M.; Panageas, K. S.; Norton, L.; more...
Clinical Cancer Research (2004)

Fulltext@MSK | Save

The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma

Journal Article

Lai, R.; Dang, C. T.; Malkin, M. G.; Abrey, L. E.
Cancer (2004)

Fulltext@MSK | Save

Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer

Journal Article

Dang, C. T.; D'Andrea, G. M.; Moynahan, M. E.; Dickler, M. N.; Seidman, A. D.; Fornier, M.; Robson, M. E.; Theodoulou, M.; Lake, D.; Currie, V. E.; more...
Clinical Cancer Research (2004)

Fulltext@MSK | Save

Adjuvant therapy for breast cancer: Practical lessons from the early breast cancer trialists' collaborative group

Journal Article

Hudis, C. A.; Dang, C. T.
Breast Disease (2004)

Fulltext@MSK | Save

Risk models for neutropenia in patients with breast cancer

Journal Article

Dang, C. T.; Fornier, M. N.; Hudis, C. A.
Oncology (Norwalk) (2003)

Fulltext@MSK | Save

Dose-dense treatment prolongs disease-free survival of women with node positive breast cancer

Journal Article

Dang, C.; Seidman, A. D.
Cancer Treatment Reviews (2003)

Fulltext@MSK | Save

[Commentary on] Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trial

Journal Article

Dang, C.
Women's Oncology Review (2002)

Fulltext@MSK | Save

Potential role of selective COX-2 inhibitors in cancer management

Journal Article

Dang, C. T.; Shapiro, C. L.; Hudis, C. A.
Oncology (Norwalk) (2002)

Fulltext@MSK | Save

[Commentary on] Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial

Journal Article

Dang, C.
Women's Oncology Review (2001)

Fulltext@MSK | Save